Lenvakast 4mg Capsule 30s

Introduction to Lenvakast 4mg Capsule 30s

Lenvakast 4mg Capsule 30s is a medication in capsule form primarily used to treat certain types of cancer. It is effective in managing conditions such as thyroid cancer and renal cell carcinoma by slowing down the growth and spread of tumors.

Composition of Lenvakast 4mg Capsule 30s

Lenvakast 4mg Capsule 30s contains Lenvatinib as its active ingredient. Lenvatinib works by inhibiting proteins that promote the growth and spread of cancer cells, effectively acting as a switch to slow down tumor progression.

Uses of Lenvakast 4mg Capsule 30s

• Treatment of thyroid cancer
• Management of renal cell carcinoma
• Slowing the growth and spread of tumors

Side effects of Lenvakast 4mg Capsule 30s

• Common side effects: High blood pressure, fatigue, diarrhea
• Serious side effects: Liver problems, heart issues, severe hypertension

Precautions of Lenvakast 4mg Capsule 30s

Patients should be cautious of increased blood pressure, liver and heart problems. It is not recommended for those with severe liver impairment. Pregnant women should avoid it due to potential harm to the unborn baby. Always consult your doctor and report any unusual symptoms immediately.

How to Take Lenvakast 4mg Capsule 30s

The usual starting dose for adults is 24 mg taken once daily, at the same time each day, with or without food. Capsules should be swallowed whole, not crushed or chewed. Your doctor may adjust the dose based on your response and any side effects.

Conclusion of Lenvakast 4mg Capsule 30s

Lenvakast 4mg Capsule 30s, containing Lenvatinib, belongs to the therapeutic class of cancer treatments. It is primarily used for thyroid cancer and renal cell carcinoma. Manufactured to slow tumor growth, it is essential to follow medical advice for optimal results. Lenvakast 4mg Capsule 30s is a key player in cancer management, offering hope for improved patient outcomes.